Home/Filings/4/0001674335-21-000092
4//SEC Filing

Farmakis Peter 4

Accession 0001674335-21-000092

CIK 0001674335other

Filed

Aug 9, 8:00 PM ET

Accepted

Aug 10, 9:12 PM ET

Size

33.8 KB

Accession

0001674335-21-000092

Insider Transaction Report

Form 4
Period: 2021-08-06
Farmakis Peter
EVP & President, Australasia
Transactions
  • Exercise/Conversion

    Common Stock

    2021-08-06$6.74/sh+52,240$352,098216,126 total
  • Sale

    Common Stock

    2021-08-09$27.84/sh13,431$373,910158,886 total
  • Exercise/Conversion

    Common Stock Option (Right to Buy)

    2021-08-0652,2400 total
    Exercise: $6.74Exp: 2024-05-02Common Stock (52,240 underlying)
  • Exercise/Conversion

    Common Stock Option (Right to Buy)

    2021-08-0610,5600 total
    Exercise: $9.97Exp: 2024-05-02Common Stock (10,560 underlying)
  • Exercise/Conversion

    Common Stock Option (Right to Buy)

    2021-08-063,5200 total
    Exercise: $14.07Exp: 2024-05-02Common Stock (3,520 underlying)
  • Exercise/Conversion

    Common Stock Option (Right to Buy)

    2021-08-099,9110 total
    Exercise: $20.96Exp: 2029-02-25Common Stock (9,911 underlying)
  • Exercise/Conversion

    Common Stock

    2021-08-09$18.79/sh+3,520$66,141246,786 total
  • Sale

    Common Stock

    2021-08-06$28.00/sh62,800$1,758,632193,897 total
  • Sale

    Common Stock

    2021-08-06$28.13/sh5,000$140,673188,897 total
  • Sale

    Common Stock

    2021-08-09$27.86/sh25,050$697,973133,836 total
  • Exercise/Conversion

    Common Stock

    2021-08-06$10.76/sh+13,060$140,526239,746 total
  • Exercise/Conversion

    Common Stock

    2021-08-06$14.07/sh+3,520$49,526243,266 total
  • Exercise/Conversion

    Common Stock

    2021-08-09$20.96/sh+9,911$207,735256,697 total
  • Sale

    Common Stock

    2021-08-06$28.09/sh16,580$465,779172,317 total
  • Exercise/Conversion

    Common Stock Option (Right to Buy)

    2021-08-0613,0600 total
    Exercise: $10.76Exp: 2024-05-02Common Stock (13,060 underlying)
  • Exercise/Conversion

    Common Stock Option (Right to Buy)

    2021-08-093,5200 total
    Exercise: $18.79Exp: 2024-05-02Common Stock (3,520 underlying)
  • Exercise/Conversion

    Common Stock

    2021-08-06$9.97/sh+10,560$105,283226,686 total
Footnotes (10)
  • [F1]Certain shares sold by the reporting person to cover tax obligation associated with the vesting of an RSU award on August 6, 2021.
  • [F10]This option is vested with respect to 15,006 underlying shares and will vest with respect to the remaining 7,503 underlying shares on February 25, 2022.
  • [F2]The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.87 to $28.30 per share, inclusive. The reporting person undertakes to provide to JELD-WEN Holding, Inc., any security holder of JELD-WEN Holding, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares soldat each separate price within the range set forth in this footnote.
  • [F3]The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.18 to $28.19 per share, inclusive. The reporting person undertakes to provide to JELD-WEN Holding, Inc., any security holder of JELD-WEN Holding, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.13 to $28.08 per share, inclusive. The reporting person undertakes to provide to JELD-WEN Holding, Inc., any security holder of JELD-WEN Holding, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.75 to $27.97 per share, inclusive. The reporting person undertakes toprovide to JELD-WEN Holding, Inc., any security holder of JELD-WEN Holding, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares soldat each separate price within the range set forth in this footnote.
  • [F6]The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.75 to $27.98 per share, inclusive. The reporting person undertakes toprovide to JELD-WEN Holding, Inc., any security holder of JELD-WEN Holding, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares soldat each separate price within the range set forth in this footnote.
  • [F7]This option is fully vested as of May 2, 2019.
  • [F8]This option is fully vested as of May 2, 2015.
  • [F9]This option is fully vested as of May 2, 2016.

Issuer

JELD-WEN Holding, Inc.

CIK 0001674335

Entity typeother

Related Parties

1
  • filerCIK 0001695321

Filing Metadata

Form type
4
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 9:12 PM ET
Size
33.8 KB